Výsledky vyhledávání - "Vanga K Marius"

Semiannual Treatment of Albendazole Alone is Efficacious for Treatment of Lymphatic Filariasis: A Randomized Open-label Trial in Cote d’Ivoire

Autor: Britt J. Andersen, Vanga K Marius, Olivier Kouadio Kouadio, Charles W. Goss, Gary J. Weil, Allassane Ouattara, Catherine M. Bjerum, Daphne Lew, Meite Aboulaye, Benjamin G. Koudou, Christopher L. King

Publikováno v: Clinical Infectious Diseases. 74:2200-2208

Background Ivermectin (IVM) plus albendazole (ALB), or IA, is widely used in mass drug administration (MDA) programs that aim to eliminate lymphatic filariasis (LF) in Africa. However, IVM can cause severe adverse events in persons with heavy Loa loa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca00e0413784f4be72e82be999a8b6b3
https://doi.org/10.1093/cid/ciab194

Zobrazit plný text záznamu

Efficacy and Safety of a Single Dose of Ivermectin, Diethylcarbamazine, and Albendazole for Treatment of Lymphatic Filariasis in Côte d’Ivoire: An Open-label Randomized Controlled Trial

Autor: Olivier Kouadio Kouadio, Christopher L. King, Catherine M. Bjerum, Britt J. Andersen, Benjamin G. Koudou, Allassane Ouattara, Meite Aboulaye, Gary J. Weil, Vanga K Marius

Publikováno v: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America

Background Improved drug regimens are needed to accelerate elimination of lymphatic filariasis in Africa. This study determined whether a single co-administered dose of ivermectin plus diethylcarbamazine plus albendazole [IDA] is noninferior to stand

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85a6e9d777650b631cd9bffb52dc1bc9
https://doi.org/10.1093/cid/ciz1050

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání